Insufficient scRNA-seq data for expression of DCLRE1B at single-cell level.
Insufficient scRNA-seq data for expression of DCLRE1B at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 99% | 327.59 | 179 / 180 | 100% | 13.49 | 429 / 430 |
lung | 100% | 487.89 | 576 / 578 | 99% | 11.84 | 1149 / 1155 |
intestine | 100% | 398.41 | 965 / 966 | 99% | 11.89 | 522 / 527 |
breast | 100% | 450.28 | 459 / 459 | 99% | 14.08 | 1106 / 1118 |
brain | 99% | 371.77 | 2626 / 2642 | 99% | 14.20 | 701 / 705 |
esophagus | 100% | 432.35 | 1443 / 1445 | 99% | 12.39 | 181 / 183 |
skin | 100% | 658.23 | 1809 / 1809 | 99% | 14.79 | 465 / 472 |
uterus | 100% | 401.15 | 170 / 170 | 98% | 17.38 | 452 / 459 |
bladder | 100% | 362.71 | 21 / 21 | 97% | 11.43 | 487 / 504 |
stomach | 96% | 228.24 | 346 / 359 | 99% | 12.02 | 284 / 286 |
thymus | 100% | 302.21 | 651 / 653 | 94% | 7.08 | 571 / 605 |
prostate | 98% | 233.32 | 240 / 245 | 84% | 4.59 | 423 / 502 |
kidney | 98% | 238.20 | 87 / 89 | 83% | 6.47 | 749 / 901 |
pancreas | 81% | 113.96 | 265 / 328 | 93% | 7.90 | 166 / 178 |
adrenal gland | 95% | 260.11 | 246 / 258 | 49% | 2.47 | 113 / 230 |
liver | 83% | 118.91 | 187 / 226 | 60% | 3.82 | 242 / 406 |
adipose | 100% | 526.05 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 542.65 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 12.69 | 29 / 29 |
spleen | 100% | 499.06 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 20.14 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.85 | 1 / 1 |
peripheral blood | 98% | 525.01 | 908 / 929 | 0% | 0 | 0 / 0 |
heart | 88% | 153.49 | 759 / 861 | 0% | 0 | 0 / 0 |
muscle | 76% | 97.14 | 611 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 73% | 3.73 | 58 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006303 | Biological process | double-strand break repair via nonhomologous end joining |
GO_0036297 | Biological process | interstrand cross-link repair |
GO_0031848 | Biological process | protection from non-homologous end joining at telomere |
GO_0031627 | Biological process | telomeric loop formation |
GO_0010833 | Biological process | telomere maintenance via telomere lengthening |
GO_0016233 | Biological process | telomere capping |
GO_0000723 | Biological process | telomere maintenance |
GO_0031860 | Biological process | telomeric 3' overhang formation |
GO_0005813 | Cellular component | centrosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016604 | Cellular component | nuclear body |
GO_0005737 | Cellular component | cytoplasm |
GO_0000781 | Cellular component | chromosome, telomeric region |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0008409 | Molecular function | 5'-3' exonuclease activity |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0035312 | Molecular function | 5'-3' DNA exonuclease activity |
GO_0008800 | Molecular function | beta-lactamase activity |
GO_0005515 | Molecular function | protein binding |
GO_0003684 | Molecular function | damaged DNA binding |
Gene name | DCLRE1B |
Protein name | 5' exonuclease Apollo (EC 3.1.-.-) (Beta-lactamase DCLRE1B) (EC 3.5.2.6) (DNA cross-link repair 1B protein) (SNM1 homolog B) (SNMIB) (hSNM1B) 5' exonuclease Apollo (EC 3.5.2.6) (DNA cross-link repair 1B protein) (SNM1 homolog B) DNA cross-link repair 1B |
Synonyms | SNM1B |
Description | FUNCTION: 5'-3' exonuclease that plays a central role in telomere maintenance and protection during S-phase. Participates in the protection of telomeres against non-homologous end-joining (NHEJ)-mediated repair, thereby ensuring that telomeres do not fuse. Plays a key role in telomeric loop (T loop) formation by being recruited by TERF2 at the leading end telomeres and by processing leading-end telomeres immediately after their replication via its exonuclease activity: generates 3' single-stranded overhang at the leading end telomeres avoiding blunt leading-end telomeres that are vulnerable to end-joining reactions and expose the telomere end in a manner that activates the DNA repair pathways. Together with TERF2, required to protect telomeres from replicative damage during replication by controlling the amount of DNA topoisomerase (TOP1, TOP2A and TOP2B) needed for telomere replication during fork passage and prevent aberrant telomere topology. Also involved in response to DNA damage: plays a role in response to DNA interstrand cross-links (ICLs) by facilitating double-strand break formation. In case of spindle stress, involved in prophase checkpoint. Possesses beta-lactamase activity, catalyzing the hydrolysis of penicillin G and nitrocefin . Exhibits no activity towards other beta-lactam antibiotic classes including cephalosporins (cefotaxime) and carbapenems (imipenem) . . |
Accessions | A0A3B3IT16 A0A3B3ITQ0 ENST00000466480.2 ENST00000650450.2 ENST00000648795.1 Q9H816 ENST00000650596.1 |